| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 06/18/2008 | EP1932856A2 IL-8 inhibitors |
| 06/18/2008 | EP1932839A1 Indolecarboxylic acid derivative having pgd2 receptor antagonistic activity |
| 06/18/2008 | EP1932539A2 Signal-1/Signal-2 bifunctional peptide inhibitors |
| 06/18/2008 | EP1932538A1 Biodegradable nanoparticle having t-cell recognizable epitope peptide immobilized thereon or encapsulated therein |
| 06/18/2008 | EP1932537A1 Expression of transgenic T cell receptors in LAK-T cells |
| 06/18/2008 | EP1932522A1 Therapeutic agent for liver disease containing 2-amino-1,3-propanediol derivative as active ingredient and therapeutic method for liver disease |
| 06/18/2008 | EP1931779A1 Novel peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity |
| 06/18/2008 | EP1931710A2 Engineered anti-il-23 antibodies |
| 06/18/2008 | EP1931674A2 Deazapurines useful as inhibitors of janus kinases |
| 06/18/2008 | EP1931667A1 Pyrido-pyridimidine derivatives useful as antiinflammatory agents |
| 06/18/2008 | EP1931666A1 Imidazopyridine derivatives as a2b adenosine receptor antagonists |
| 06/18/2008 | EP1931665A1 1-[[1-[(2-amin0-6-methyl-4-pyridinyl)methyl]-4-flu0r0-4-piperidinyl,]carbonyl]-4-[2-(2-pyridinyl)-3h-imidaz0[4, 5-b]pyridin-3-yl]piperidine useful as histamine h3 antagonist |
| 06/18/2008 | EP1931371A1 Peptides capable of modulating the function of tirc7 |
| 06/18/2008 | EP1443937B1 Substituted 1,4-benzodiazepines and uses thereof for the treatment of cancer |
| 06/18/2008 | EP1385541B1 Immunostimulant compositions comprising an aminoalkyl glucosaminide phosphate and qs-21 |
| 06/18/2008 | EP1228203B1 Peptide (virip) which inhibits a circulating virus in humans and the use thereof |
| 06/18/2008 | CN101203607A Anti-CD-20 monoclonal antibody |
| 06/18/2008 | CN101203516A Purine and imidazopyridine derivatives for immunosuppression |
| 06/18/2008 | CN101203510A Carbon-linked substituted piperidines and derivatives thereof used as histamine H3 antagonists |
| 06/18/2008 | CN101203503A Novel thiophene derivatives |
| 06/18/2008 | CN101203237A Use of interferon gamma for treatment of interleukin-10 deficiency |
| 06/18/2008 | CN101203228A Composition comprising isoorientin for suppressing histamine |
| 06/18/2008 | CN101203223A Pharmaceutical composition comprising amorphous rosiglitazone |
| 06/18/2008 | CN101203214A Beta-2 adrenoceptor agonists for treating connective tissue diseases of the skin |
| 06/18/2008 | CN101200741A Synthesis of conjugated linoleic acid glyceride derivatives based on enzyme method |
| 06/18/2008 | CN101200497A Jellyfish derived kindócollagen and preparation technique thereof |
| 06/18/2008 | CN101200488A Novel biogastrone acid derivatives, preparation method and medical uses thereof |
| 06/18/2008 | CN101200465A Decahydronaphthalene compounds and medical uses thereof |
| 06/18/2008 | CN101200450A 2,6-quinolinyl and 2,6-naphthyl derivatives, processes for preparing them and their uses as vla-4 inhibitors |
| 06/18/2008 | CN101199836A Stage releasing CsA solid tiny milk agent and tiny milk curing method thereof |
| 06/18/2008 | CN101199683A Chinese medicine for treating skin disease and preparing method thereof |
| 06/18/2008 | CN101199682A Medicinal oil medicament for treating anaphylactic dermatitis |
| 06/18/2008 | CN101199681A Oral administration Chinese medicine for treating chronicity eczema |
| 06/18/2008 | CN101199672A Chinese medicine health care wine containing function of regulating human body immunity |
| 06/18/2008 | CN101199665A Medicament of strengthening livestock immunity |
| 06/18/2008 | CN101199643A Compound agent for cultivating German mirror carp non-specificity immunity and using method thereof |
| 06/18/2008 | CN101199626A Powders medicament for treating anal eczema |
| 06/18/2008 | CN101199558A Compound probiotics for poultry and preparing method thereof |
| 06/18/2008 | CN101199537A Hif hydroxylase inhibitors |
| 06/18/2008 | CN101199512A Hif hydroxylase inhibitors |
| 06/18/2008 | CN101199503A Hif hydroxylase inhibitors |
| 06/18/2008 | CN101199502A Hif hydroxylase inhibitors |
| 06/18/2008 | CN101199501A HIF hydroxylase inhibitors |
| 06/18/2008 | CN101199348A Composite marrow medicinal granule and its preparation method |
| 06/18/2008 | CN101199321A Feed-stuff additive for improving meat quality of avian fed with microorganism and its preparation method |
| 06/18/2008 | CN100394921C Freeze-drying powder for injecting lentinan and its content determination |
| 06/17/2008 | US7388078 Nucleic acids encoding polypeptides having chips activity |
| 06/17/2008 | US7388075 Medicament containing activated antithrombin III |
| 06/17/2008 | US7388011 Inhibiting the proteolytic activity of cathepsin S; 4-{3-[5-Acetyl-3-(4-chloro-phenyl)-4,5,6,7-tetrahydro-pyrazolo[4,3-c]pyridin-1-yl]-2-hydroxy-propyl}-3,4,5,6-tetrahydro-2H-[1,2']bipyrazinyl-3'-carbonitrile; antiarthritic agent; autoimmune disease: lupus, rheumatoid arthritis, and asthma |
| 06/17/2008 | US7387792 Pharmaceutical composition for compressed annular tablet with molded triturate tablet for both intraoral and oral administration |
| 06/17/2008 | US7387776 Human monoclonal antibodies against CD30 |
| 06/17/2008 | CA2439152C Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 06/17/2008 | CA2395193C Pyrrolidine derivatives as cyclic amp-specific phosphodiesterase inhibitors |
| 06/17/2008 | CA2393749C Substituted 8-arylquinoline phosphodiesterase-4 inhibitors |
| 06/17/2008 | CA2391076C Solutions containing epinastin |
| 06/17/2008 | CA2356380C Immunosuppressive effects of pteridine derivatives |
| 06/17/2008 | CA2294457C Pharmaceutical composition for application to mucosa |
| 06/17/2008 | CA2261762C Substituted 2(2,6-dioxopiperidin-3-yl)phthalimides and -1-oxoisoindolines and method of reducing tnf-alpha levels |
| 06/17/2008 | CA2255062C Process of purification of cyclosporin |
| 06/17/2008 | CA2247336C Parapoxviruses containing foreign dna, their production and their use in vaccines |
| 06/17/2008 | CA2188892C Use of an yttrium salt in a compound for the treatment of sensitive skin |
| 06/17/2008 | CA2187162C Dna encoding precursor of interleukin-1.beta. converting enzyme-related cysteine proteinase iii (icerel iii) |
| 06/17/2008 | CA2177667C Mammalian vaccine compositions comprising squalene or squalane, lecithin and a polyoxyethylene sorbitan ester as an adjuvant |
| 06/17/2008 | CA2117193C Vaccine comprising part of constant region of ige for treatment of ige-medicated allergic reactions |
| 06/17/2008 | CA1341575C Tumor necrosis factor (tnf) inhibitory protein and its purification |
| 06/12/2008 | WO2008070861A2 Methods and compositions for treating systemic lupus erythematosus |
| 06/12/2008 | WO2008069688A2 Methods for treating inflammatory disease by administering aldehydes and derivatives thereof |
| 06/12/2008 | WO2008068548A1 Use of inhibitors of the glycosylation process for the prevention and treatment of genetic diseases |
| 06/12/2008 | WO2008067756A1 3-pyrrolo-cyclohexylene-2-dihydro-indolinone derivatives and uses thereof |
| 06/12/2008 | WO2008047134A3 Antibody molecules which bind il-17a and il-17f |
| 06/12/2008 | WO2008025964A3 Antibodies to an epitope of agr2. assays and hybridomas |
| 06/12/2008 | WO2007110237A3 Amide derivatives and their application for the treatment of g protein related diseases |
| 06/12/2008 | WO2007048857A8 Use of tgf-$g(b)1 inhibitor peptides in the preparation of an immune response modulating agent |
| 06/12/2008 | WO2007028968A9 Method of treating myasthenia gravis |
| 06/12/2008 | US20080140138 Inhibition of inflammatory cytokine production by stimulation of brain muscarinic receptors |
| 06/12/2008 | US20080139666 Anti-Inflammatory and Psoriasis Treatment and Protein Kinase Inhibition by Hydroxy Stilbenes and Novel Stilbene Derivatives and Analogues |
| 06/12/2008 | US20080139642 Aryl ethers of dihydroartemisnin such as 4-methoxycarbonylmethyl phenyl-dihydroartemisinine ether; immunosuppressants; dosage forms including tablets, ointments and suppositories; side effect reduction over cyclosporin A |
| 06/12/2008 | US20080139636 Adamantane derivatives |
| 06/12/2008 | US20080139622 Decahydronaphthalene Compounds |
| 06/12/2008 | US20080139613 4-{(1R,3R)-1-(3,5-difluorophenyl)-3-[4-(3-ethyl-5-isopropyl-4H-1,2,4-triazol-4-yl)piperidin-1-yl]butyl}-1-(methylsulfonyl)piperidine; for treatment of CCR5 disease states |
| 06/12/2008 | US20080139612 Chemical Compound |
| 06/12/2008 | US20080139583 Phosphodiesterase 4 inhibitors |
| 06/12/2008 | US20080139582 Inhibitors of bruton's tyrosine kinase |
| 06/12/2008 | US20080139576 5-Substituted 1,1-Dioxo- 1,2,5- Thiadiazolidin-3-One Derivatives |
| 06/12/2008 | US20080139567 Psychological disorders; central nervous system disorders; antidepressants; anxiolytic agents; stress reliever; irritable bowel syndrome |
| 06/12/2008 | US20080139558 Quinolones useful as inducible nitric oxide synthase inhibitors |
| 06/12/2008 | US20080139557 [5-(Pyridin-2-ylamino)-6-oxo-1,6-dihydro-pyridin-3-yl]-(3-amido)-benzene derivatives; anticarcinogenic, antiproliferative, antiallergen, and antiinflammatory agents; lymphoma, leukemia, autoimmune diseases; Bruton's tyrosine kinase inhibitors |
| 06/12/2008 | US20080139503 Inhibiting FGF growth factor with heparins; antitumor agents; angiogenesis inhibitor; antidiabetic agent treating diabetic retinopathy; antiinflammatory agent; treating retrolenticular fibroplasia, psoriasis, restenosis after angioplasty and after coronary by-pass; drug delivery |
| 06/12/2008 | US20080139496 Minimising dosage required of chemotherapeutic agents for their use in antiviral, antibacterial, antiparasitic and anticancer chemotherapy; for treating neoplasms and tumours, viral, bacterial, or parasite infections |
| 06/12/2008 | US20080139494 Introducing genetic material topically or by lavage into mucosal tissue cells of an individual, including rectal, vaginal, urethral, sublingual and buccal; used to deliver genetic material that encodes protein targets for immunization against pathogen infection, hyperproliferative or autoimmune diseases |
| 06/12/2008 | US20080139476 Caspase-8 interacting proteins |
| 06/12/2008 | US20080138405 Sirolimus having a particle size of more than 400 nm and a surface modifier |
| 06/12/2008 | US20080138400 Curcumin analog or metabolite microencapsulated by a polyethylene glycolated liposome of dimyristoyl phosphatidylcholine, cholesterol, and dimyristoyl phsphatidylethanolamine; anticarcinogenic and antiproliferative agents; parenteral colloidal drug delivery system providing improved bioavailability |
| 06/12/2008 | US20080138396 rheumatoid arthritis, ulcerative colitis, Crohn's disease, inflammation, infections, osteomyelitis, atherosclerosis, organ transplant rejection, pulmonary fibrosis, sarcoidosis, and systemic sclerosis |
| 06/12/2008 | US20080138380 Use of Dermatan Sulfrates and/or Desulfated Heparins to Treat or Prevent Heparinoid-Induced Autoimmune Responses |
| 06/12/2008 | US20080138357 Vaccines Against Neisseria Meningitidis |
| 06/12/2008 | US20080138353 Alpha b-chrystallin as a therapy for inflammation |
| 06/12/2008 | US20080138347 Dsp-10 dual-specificity phosphatase |
| 06/12/2008 | US20080138341 Anti-CD70 antibody and its use for the treatment of cancer and immune disorders |
| 06/12/2008 | US20080138340 Methods and compositions for modulating the immune system of animals |